J Clin Aesthet Dermatol. 2022;15(5):47–58. by Lauren Hoffman, MD and Sabrina Fabi, MD Dr. Hoffman is with the Albert Einstein College of Medicine and Montefiore Medical Center, Department of Medicine
J Clin Aesthet Dermatol. 2021;14(10):27–31. by Yan Wu, MD, PhD; Chengxin Li, MD; Julia Garcia, PhD; and Sarah Baradaran, PharmD Dr. Wu is with Peking University First Hospital in Beijing,
J Clin Aesthet Dermatol. 2021;14(8):34–40. by Sheila C. Barbarino, MD, FACS; Jani A. J. van Loghem, MD; Cheryl M. Burgess, MD, FAAD; and Niamh Corduff, MBBS, FRACS Dr. Barbarino is
J Clin Aesthet Dermatol. 2021;14(8):57–60. by Nuntida Salakshna, MD; Wilai Thanasarnaksorn, MD;and Thanan Supasiri, MD Dr. Thanasarnaksorn is with the Samitivej Esthetics Institute, Samitivej Sukhumvit Hospital, and the Division of
J Clin Aesthet Dermatol. 2021;14(3):42–45. by Andres Luque, MD; AIDA PAOLA ROJAS, MD; Andrea Ortiz-Florez, MD; and Juliana Perez-Bernal, MD All authors are with Hospital Universitario Centro Dermatológico Federico Lleras
J Clin Aesthet Dermatol. 2021;14(2):E69–E88. by Riekie Smit, MD; Elena Gubanova, MD; Joely Kaufman, MD; Marina Landau, MD; Beatriz Molina, MD; Bill Andriopoulos, PhD; Pascal Maisonobe, MSc; Inna Prygova, MD;
Dear Editor: There is no doubt now that the use of botulinum toxin (BoNT) in aesthetics has been a revolution for the noninvasive treatment of patients. In the last several
J Clin Aesthet Dermatol. 2020;13(12):22–26. by Enayat Mohamed Atwa, MD; Mohamed Mahmoud Nasr, MD; and Howyda M. Ebrahim, MD Dr. Atwa is a Professor of Dermatology, Venereology, and Andrology and
J Clin Aesthet Dermatol. 2020;13(12):E56–E83 by Mark Nestor, MD, PhD; Joel L. Cohen, MD; Marina Landau, MD; Said Hilton, MD; Andreas Nikolis, MD; Syed Haq, MBBS, PhD; Maurizio Viel, MD;
Dear Editor: No other single medical product has revolutionized and quite literally defined the aesthetic medicine field like botulinum toxin injections.1–5 Every year, a growing number of patients experience the
Objective: We assessed clinical effectiveness, longevity of treatment effects, and patient satisfaction with incobotulinumtoxinA for glabellar frown lines (GFL) treatment in Asian patients.
by Hamzah Mustak, MD; Michael Rafaelof, BS; Robert Alan Goldberg, MD; and Daniel Rootman, MD Drs. Mustak, Goldberg, and Rootman and Mr. Rafaelof are with the Stein Eye Institute, Division
by Gabriele F. Muti, MD, and Matteo Basso, MD Dr. Muti is with the Department of Plastic Surgery, European Dermatological Institute, in Milan, Italy. Dr. Basso is with the Studio
by Yates Y.Y. Chao, MD; Chiranjiv Chhabra, MBBS, DVD; Niamh Corduff, MBBS, FRACS; Sabrina Guillen FABI, MD; Martina Kerscher, MD; Stephanie C.K. Lam, MBChB; Tatjana Pavicic, MD; Berthold Rzany, MD,
by Dawnielle C. Endly, DO, and Richard A. Miller, DO Dr. Endly is with Advanced Dermatology Skin Cancer and Laser Surgery Center in Aurora, Colorado. Dr. Miller is with Nova
Ashley Collins, MD; Department of Biochemistry, North Carolina State University; Adnan Nasir, MD, Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina Abstract Nanotechnology is a rapidly growing
Richard G. Fried, MD, PhD, Clinical Director, Yardley Dermatology Associates, Yardley, Pennsylvania; Wm. Philip Werschler, MD, Assistant Clinical Professor of Medicine and Dermatology, University of Washington, Seattle, Washington; Tracy Floirendo,